[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Prime Medicine Inc (PRME)

Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Prime Medicine Inc 60 First Street Cambridge MA 02141 USA

https://primemedicine.com Employees: 146 P: 617-465-0013

Sector:

Medical

Description:

Prime Medicine Inc. is a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies. Prime Medicine Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 574,362
Enterprise Value, $K 511,332
Shares Outstanding, K 180,617
Float, K 151,646
% Float 83.96%
Short Interest, K 30,820
Short Float 17.06%
Days to Cover 11.21
Short Volume Ratio 0.40
% of Insider Shareholders 16.04%
% of Institutional Shareholders 70.37%

Financials:

Annual Sales, $ 4,630 K
Annual Net Income, $ -201,140 K
Last Quarter Sales, $ 860 K
Last Quarter Net Income, $ -49,120 K
EBIT, $ -206,610 K
EBITDA, $ -201,230 K

Growth:

1-Year Return 29.43%
3-Year Return -76.59%
5-Year Return 0.00%
5-Year Revenue Growth -11.13%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.28 on 05/07/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -1.23
EPS Growth vs. Prev Qtr -27.27%
EPS Growth vs. Prev Year 30.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 09/10/19
Dividend Payable Date 09/12/19
Dividend Payout Ratio 0.00%

PRME Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -188.82%
Return-on-Assets % -60.97%
Profit Margin % -4,344.28%
Debt/Equity 0.00
Price/Sales 121.66
Price/Cash Flow N/A
Price/Book 7.35
Book Value/Share 0.42
Interest Coverage -2.84
60-Month Beta 2.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.